Abyrx, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Abyrx, Inc. - overview
Established
2013
Location
Irvington, NY, US
Primary Industry
Medical Devices & Equipment
About
Abyrx, Inc. is a medical technology company specializing in advanced surgical therapeutic devices, particularly the MONTAGE® system, which enhances surgical procedures for medical professionals. Founded in 2013 and headquartered in Irvington, US, Abyrx, Inc. focuses on developing surgical devices.
In December 2016, the company raised USD 10 mn in funding from BB Biotech, Canaan Partners, and new investor MedEdge, Inc. The firm has conducted one deal to date, with its most recent funding round occurring in December 2016, which brought the total amount raised to USD 10 mn. The company was established by a team of executives with a history in the medical technology sector. ABYRX specializes in the development and distribution of advanced surgical therapeutic devices, focusing primarily on their flagship product, MONTAGE®.
Designed to aid medical professionals in surgical settings, MONTAGE® features a user-friendly interface that enhances precision and minimizes complications. ABYRX serves a diverse clientele, including hospitals and surgical centers within the US and selected international markets in Europe and Asia, targeting healthcare professionals in need of reliable surgical tools. ABYRX generates revenue through direct sales and partnerships with healthcare institutions, operating on a B2B model. The company supplies its surgical devices to hospitals and surgical centers, where bulk orders are typically placed by procurement teams.
Transactions are structured around bulk pricing agreements based on order volume and frequency. MONTAGE® and other proprietary devices are positioned as premium solutions, marketed for their advanced capabilities, and the revenue model includes both one-time purchases and recurring contracts for device replenishment and maintenance services. In December 2016, Abyrx, Inc. raised USD 10 mn in funding to support its growth initiatives.
The company is focused on expanding its product line, which includes upcoming enhancements to the MONTAGE® system, aimed at improving usability and effectiveness in surgical procedures. Abyrx plans to enter new markets in Europe and Asia by 2020, leveraging the recent funding to support product development and market entry strategies.
Current Investors
Canaan Partners, BB Biotech, MedEdge, Inc.
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Equipment Distributors, Biomaterials
Website
www.abyrx.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Abyrx, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Merger | Completed | Doctors Research Group, Inc., ORTHOCON, Inc. | - |
Displaying 1 - 1 of 1
Abyrx, Inc. - employee data
Abyrx, Inc. - key contacts
| Name | Position | Start Date | End Date | Vcard | Bio | ||
|---|---|---|---|---|---|---|---|
| Chief Executive Officer & President | BM |
BM Board Member
Want to see more?
Request a demo for full access to this profile
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.